Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2 (original) (raw)

• Bosch F, Jares P, Campo E, Lopez-Guillermo A, Piris MA, Villamor N et al. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994; 84: 2726–2732.
  CAS PubMed Google Scholar
• Quintanilla-Martinez L, Thieblemont C, Fend F, Kumar S, Pinyol M, Campo E et al. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor. Am J Pathol 1998; 153: 175–182.
  Article CAS PubMed PubMed Central Google Scholar
• Quintanilla-Martinez L, Davies-Hill T, Fend F, Calzada-Wack J, Sorbara L, Campo E et al. Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis. Blood 2003; 101: 3181–3187.
  Article CAS PubMed Google Scholar
• Fernandez V, Hartmann E, Ott G, Campo E, Rosenwald A . Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. J Clin Oncol 2005; 23: 6364–6369.
  Article CAS PubMed Google Scholar
• Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ . Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 1993; 7: 331–342.
  Article CAS PubMed Google Scholar
• Sherr CJ, Roberts JM . CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501–1512.
  Article CAS PubMed Google Scholar
• Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003; 3: 185–197.
  Article CAS PubMed Google Scholar
• Slotta-Huspenina J, Koch I, Richter M, Bink K, Kremer M, Specht K et al. Cyclin D1 positive multiple myeloma: Predominance of the short, 3′UTR-deficient transcript is associated with high cyclin D1 mRNA levels in cases with t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions. Leuk Res 2008; 32: 79–88.
  Article CAS PubMed Google Scholar
• Specht K, Haralambieva E, Bink K, Kremer M, Mandl-Weber S, Koch I et al. Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels. Blood 2004; 104: 1120–1126.
  Article CAS PubMed Google Scholar
• Lovec H, Grzeschiczek A, Kowalski MB, Moroy T . Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 1994; 13: 3487–3495.
  Article CAS PubMed PubMed Central Google Scholar
• Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM . Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 1994; 13: 2124–2130.
  Article CAS PubMed PubMed Central Google Scholar
• Bea S, Ribas M, Hernandez JM, Bosch F, Pinyol M, Hernandez L et al. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 1999; 93: 4365–4374.
  CAS PubMed Google Scholar
• Jares P, Colomer D, Campo E . Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 2007; 7: 750–762.
  Article CAS PubMed Google Scholar
• Brummelkamp TR, Bernards R, Agami R . A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550–553.
  Article CAS PubMed Google Scholar
• Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D . Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002; 295: 868–872.
  Article CAS PubMed Google Scholar
• Quintanilla-Martinez L, Pittaluga S, Miething C, Klier M, Rudelius M, Davies-Hill T et al. NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma. Blood 2006; 108: 2029–2036.
  Article CAS PubMed Google Scholar
• Koch I, Slotta-Huspenina J, Hollweck R, Anastasov N, Hofler H, Quintanilla-Martinez L et al. Real-time quantitative RT–PCR shows variable, assay-dependent sensitivity to formalin fixation: implications for direct comparison of transcript levels in paraffin-embedded tissues. Diagn Mol Pathol 2006; 15: 149–156.
  Article CAS PubMed Google Scholar
• Specht K, Kremer M, Muller U, Dirnhofer S, Rosemann M, Hofler H et al. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections. Clin Cancer Res 2002; 8: 2902–2911.
  CAS PubMed Google Scholar
• Nusse M, Beisker W, Kramer J, Miller BM, Schreiber GA, Viaggi S et al. Measurement of micronuclei by flow cytometry. Methods Cell Biol 1994; 42 (Part B): 149–158.
  Article PubMed Google Scholar
• Pscherer A, Schliwka J, Wildenberger K, Mincheva A, Schwaenen C, Dohner H et al. Antagonizing inactivated tumor suppressor genes and activated oncogenes by a versatile transgenesis system: application in mantle cell lymphoma. FASEB J 2006; 20: 1188–1190.
  Article CAS PubMed Google Scholar
• Inaba T, Matsushime H, Valentine M, Roussel MF, Sherr CJ, Look AT . Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 1992; 13: 565–574.
  Article CAS PubMed Google Scholar
• Lam EW, Glassford J, Banerji L, Thomas NS, Sicinski P, Klaus GG . Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40. J Biol Chem 2000; 275: 3479–3484.
  Article CAS PubMed Google Scholar
• Mataraza JM, Tumang JR, Gumina MR, Gurdak SM, Rothstein TL, Chiles TC . Disruption of cyclin D3 blocks proliferation of normal B-1a cells, but loss of cyclin D3 is compensated by cyclin D2 in cyclin D3-deficient mice. J Immunol 2006; 177: 787–795.
  Article CAS PubMed Google Scholar
• Sherr CJ, Roberts JM . Living with or without cyclins and cyclin-dependent kinases. Genes Dev 2004; 18: 2699–2711.
  Article CAS PubMed Google Scholar
• Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E et al. Mouse development and cell proliferation in the absence of D-cyclins. Cell 2004; 118: 477–491.
  Article CAS PubMed Google Scholar
• Malumbres M, Sotillo R, Santamaria D, Galan J, Cerezo A, Ortega S et al. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 2004; 118: 493–504.
  Article CAS PubMed Google Scholar
• Salaverria I, Perez-Galan P, Colomer D, Campo E . Mantle cell lymphoma: from pathology and molecular pathogenesis to new therapeutic perspectives. Haematologica 2006; 91: 11–16.
  CAS PubMed Google Scholar
• Hipp S, Ringshausen I, Oelsner M, Bogner C, Peschel C, Decker T . Inhibition of the mammalian target of rapamycin and the induction of cell cycle arrest in mantle cell lymphoma cells. Haematologica 2005; 90: 1433–1434.
  CAS PubMed Google Scholar
• Hofmann WK, de Vos S, Tsukasaki K, Wachsman W, Pinkus GS, Said JW et al. Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood 2001; 98: 787–794.
  Article CAS PubMed Google Scholar
• Korz C, Pscherer A, Benner A, Mertens D, Schaffner C, Leupolt E et al. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. Blood 2002; 99: 4554–4561.
  Article CAS PubMed Google Scholar
• Witzig TE . Current treatment approaches for mantle-cell lymphoma. J Clin Oncol 2005; 23: 6409–6414.
  Article CAS PubMed Google Scholar
• Venkataraman G, Maududi T, Ozpuyan F, Bahar HI, Izban KF, Qin JZ et al. Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment. Leuk Res 2006; 30: 1377–1384.
  Article CAS PubMed Google Scholar
• Pham LV, Tamayo AT, Yoshimura LC, Lo P, Ford RJ . Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis. J Immunol 2003; 171: 88–95.
  Article CAS PubMed Google Scholar
• Heider U, Kaiser M, Sterz J, Zavrski I, Jakob C, Fleissner C et al. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma. Eur J Haematol 2006; 76: 42–50.
  Article CAS PubMed Google Scholar
• Kawamata N, Chen J, Koeffler HP . Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells. Blood 2007; 110: 2667–2673.
  Article CAS PubMed PubMed Central Google Scholar
• Perez-Galan P, Roue G, Villamor N, Montserrat E, Campo E, Colomer D . The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 2006; 107: 257–264.
  Article CAS PubMed Google Scholar